Financhill
Sell
19

LNXSF Quote, Financials, Valuation and Earnings

Last price:
$20.16
Seasonality move :
-4.09%
Day range:
$20.16 - $20.16
52-week range:
$18.65 - $36.00
Dividend yield:
0.56%
P/E ratio:
5.60x
P/S ratio:
0.27x
P/B ratio:
0.38x
Volume:
900
Avg. volume:
974
1-year change:
-16.61%
Market cap:
$1.7B
Revenue:
$6.9B
EPS (TTM):
-$3.12

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, LANXESS AG has -- downside to fair value with a price target of -- per share.

LNXSF vs. S&P 500

  • Over the past 5 trading days, LANXESS AG has underperformed the S&P 500 by -0.18% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • LANXESS AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • LANXESS AG revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter LANXESS AG reported revenues of $1.6B.

Earnings Growth

  • LANXESS AG earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter LANXESS AG reported earnings per share of -$1.04.
Enterprise value:
4.2B
EV / Invested capital:
0.56x
Price / LTM sales:
0.27x
EV / EBIT:
176.86x
EV / Revenue:
0.65x
PEG ratio (5yr expected):
0.02x
EV / Free cash flow:
50.92x
Price / Operating cash flow:
21.16x
Enterprise value / EBITDA:
5.82x
Gross Profit (TTM):
$1.3B
Return On Assets:
-2.64%
Net Income Margin (TTM):
-4.13%
Return On Equity:
-5.67%
Return On Invested Capital:
-3.42%
Operating Margin:
-0.82%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $7.7B $6.9B $6.5B $1.8B $1.6B
Gross Profit $1.6B $1.3B $1.3B $383.4M $296.8M
Operating Income $54.2M -$22.2M $23.8M $36.3M -$12.9M
EBITDA $663.3M $1.1B $723.2M $188.9M $142.6M
Diluted EPS $12.78 -$10.80 -$3.12 $0.01 -$1.04
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $4.2B $5.3B $3.3B $3.7B $3.2B
Total Assets $11.1B $12B $11.2B $10.5B $9.6B
Current Liabilities $1.9B $2.8B $1.2B $1.9B $1.2B
Total Liabilities $6.9B $7.2B $5.2B $5.7B $5B
Total Equity $4.2B $4.8B $6B $4.9B $4.6B
Total Debt $3.3B $3.4B $3.1B $2.7B $2.8B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $767.4M $381.6M $436.2M $64.8M $61.1M
Cash From Investing $620.4M -$172.4M $295.2M $107.7M -$1.8M
Cash From Financing -$1.5B -$74.4M -$675.9M -- -$48.8M
Free Cash Flow $391.8M $50.4M $82.6M -$15.4M -$17.5M
LNXSF
Sector
Market Cap
$1.7B
$21.5M
Price % of 52-Week High
56.25%
72.73%
Dividend Yield
0.56%
0%
Shareholder Yield
3.2%
-2.68%
1-Year Price Total Return
-16.24%
13.33%
Beta (5-Year)
1.031
0.619
Dividend yield:
0.56%
Annualized payout:
$0.11
Payout ratio:
6.24%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $20.04
200-day SMA
Sell
Level $26.84
Bollinger Bands (100)
Sell
Level 20.46 - 27.82
Chaikin Money Flow
Buy
Level 14.4K
20-day SMA
Buy
Level $19.61
Relative Strength Index (RSI14)
Buy
Level 51.27
ADX Line
Buy
Level 31.3
Williams %R
Sell
Level 0
50-day SMA
Sell
Level $21.07
MACD (12, 26)
Sell
Level -0.14
25-day Aroon Oscillator
Buy
Level 96
On Balance Volume
Neutral
Level 369

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.0974)
Sell
CA Score (Annual)
Level (-0.4482)
Buy
Beneish M-Score (Annual)
Level (-2.9147)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (1.6188)
Buy
Piotroski F Score (Annual)
Level (7)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Lanxess AG is a specialty chemicals company, which engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products. It operates through the following segments: Advanced Industrial Intermediates, Specialty Additives, and Consumer Protection. The Advanced Industrial Intermediates segment includes basic and fine chemicals, organometallics, and inorganic pigments for the coloring of construction materials, paints, and coatings. The Specialty Additives segment provides additives for the rubber, plastic and paint industries, construction, and electrical industry, such as lubricants, flame retardants, plasticizers, and bromine derivatives for various applications. The Consumer Protection segment offers disinfectant, hygiene and preservative solutions, flavors and fragrances, technologies for the treatment of water and other liquids, and precursors and intermediates for the agrochemicals, pharmaceuticals, and specialty chemicals industries. The company was founded on July 1, 2004 and is headquartered in Cologne, Germany.

Stock Forecast FAQ

In the current month, LNXSF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LNXSF average analyst price target in the past 3 months is --.

  • Where Will LANXESS AG Stock Be In 1 Year?

    According to analysts, the consensus estimate is that LANXESS AG share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About LANXESS AG?

    Analysts are divided on their view about LANXESS AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that LANXESS AG is a Sell and believe this share price will rise from its current level to --.

  • What Is LANXESS AG's Price Target?

    The price target for LANXESS AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is LNXSF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for LANXESS AG is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of LNXSF?

    You can purchase shares of LANXESS AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase LANXESS AG shares.

  • What Is The LANXESS AG Share Price Today?

    LANXESS AG was last trading at $20.16 per share. This represents the most recent stock quote for LANXESS AG. Yesterday, LANXESS AG closed at $20.16 per share.

  • How To Buy LANXESS AG Stock Online?

    In order to purchase LANXESS AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Buy
80
TVTX alert for Dec 27

Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock